Octopus AIM VCT PLC : AMENDMENT Transaction in ...
Octopus AIM VCT PLC : AMENDMENT Transaction in Own Shares and Total Voting Rights
Octopus AIM VCT plc ("the Company")
19 July 2016
AMENDMENT: Purchase of own securities and total voting rights
Amendment of RNS published at 16:19 on 15 July 2016 - The total voting rights was incorrectly stated as 84,235,850 ordinary shares instead of 84,210,850 ordinary shares.
Octopus AIM VCT plc announces that on 15 July 2016 the Company purchased for cancellation 199,953 Ordinary shares at a price of 93.5p per share.
Following this transaction, the issued share capital of the Company is now 84,210,850 Ordinary shares with a nominal value of 1p each, with voting rights.
For further enquiries, please contact:
Nicola Board,
Company Secretary
Tel: 020 7710 8663
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Octopus AIM VCT PLC via Globenewswire
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.